Clinical trial
Comparison of Silac and Phenol Treatments in Primary Pilonidal Sinus Disease: A Prospective Randomized Controlled Trial With 6-Month Follow-up
NCT07420452 is registered in ClinicalTrials.gov with Izmir City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Silac and Phenol Treatments in Primary Pilonidal Sinus Disease: A Prospective Randomized Controlled Trial With 6-Month Follow-up
- Lead sponsor
- Izmir City Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 12, 2026
- Completion date
- December 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pilonidal sinus disease